These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 9329392

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Vaginal DHEA to treat menopause related atrophy: a review of the evidence.
    Panjari M, Davis SR.
    Maturitas; 2011 Sep; 70(1):22-5. PubMed ID: 21733647
    [Abstract] [Full Text] [Related]

  • 23. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
    Murphy MG, Weiss S, McClung M, Schnitzer T, Cerchio K, Connor J, Krupa D, Gertz BJ, MK-677/Alendronate Study Group.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration.
    Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Bérubé R, Bélanger P, Berger L, Gilbert L, Martel C, Balser J.
    Menopause; 2009 Mar; 16(5):897-906. PubMed ID: 19436226
    [Abstract] [Full Text] [Related]

  • 26. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
    Jolly EE, Bjarnason NH, Neven P, Plouffe L, Johnston CC, Watts SD, Arnaud CD, Mason TM, Crans G, Akers R, Draper MW.
    Menopause; 2003 Mar; 10(4):337-44. PubMed ID: 12851517
    [Abstract] [Full Text] [Related]

  • 27. Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity.
    Callies F, Fassnacht M, van Vlijmen JC, Koehler I, Huebler D, Seibel MJ, Arlt W, Allolio B.
    J Clin Endocrinol Metab; 2001 May; 86(5):1968-72. PubMed ID: 11344193
    [Abstract] [Full Text] [Related]

  • 28. Effects of dehydroepiandrosterone, Premarin and Acolbifene on histomorphology and sex steroid receptors in the rat vagina.
    Berger L, El-Alfy M, Martel C, Labrie F.
    J Steroid Biochem Mol Biol; 2005 Jul; 96(2):201-15. PubMed ID: 15979306
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen.
    Lahti E, Vuopala S, Kauppila A, Blanco G, Ruokonen A, Laatikainen T.
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):410-4. PubMed ID: 7835781
    [Abstract] [Full Text] [Related]

  • 31. DHEA, important source of sex steroids in men and even more in women.
    Labrie F.
    Prog Brain Res; 2010 Dec; 182():97-148. PubMed ID: 20541662
    [Abstract] [Full Text] [Related]

  • 32. Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women: a double-blind, placebo-controlled, and conjugated estrogens-controlled study.
    Wuttke W, Gorkow C, Seidlová-Wuttke D.
    Menopause; 2006 Dec; 13(2):185-96. PubMed ID: 16645532
    [Abstract] [Full Text] [Related]

  • 33. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
    Marcus R, Holloway L, Wells B, Greendale G, James MK, Wasilauskas C, Kelaghan J.
    J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288
    [Abstract] [Full Text] [Related]

  • 34. Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).
    Barton DL, Shuster LT, Dockter T, Atherton PJ, Thielen J, Birrell SN, Sood R, Griffin P, Terstriep SA, Mattar B, Lafky JM, Loprinzi CL.
    Support Care Cancer; 2018 Apr; 26(4):1335-1343. PubMed ID: 29164377
    [Abstract] [Full Text] [Related]

  • 35. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial.
    Zhang G, Qin L, Shi Y.
    J Bone Miner Res; 2007 Jul; 22(7):1072-9. PubMed ID: 17419678
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Science of intracrinology in postmenopausal women.
    Labrie F, Bélanger A, Pelletier G, Martel C, Archer DF, Utian WH.
    Menopause; 2017 Jun; 24(6):702-712. PubMed ID: 28098598
    [Abstract] [Full Text] [Related]

  • 38. Dried plums improve indices of bone formation in postmenopausal women.
    Arjmandi BH, Khalil DA, Lucas EA, Georgis A, Stoecker BJ, Hardin C, Payton ME, Wild RA.
    J Womens Health Gend Based Med; 2002 Jun; 11(1):61-8. PubMed ID: 11860726
    [Abstract] [Full Text] [Related]

  • 39. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.
    Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, Draper M, Christiansen C.
    N Engl J Med; 1997 Dec 04; 337(23):1641-7. PubMed ID: 9385122
    [Abstract] [Full Text] [Related]

  • 40. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F, Bélanger A, Cusan L, Candas B.
    J Clin Endocrinol Metab; 1997 Aug 04; 82(8):2403-9. PubMed ID: 9253308
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.